|
Jan has an extensive research experience. He was previously Senior Vice President, Head of Global Discovery, a position he had since the Astra-Zeneca merger in 1999. Before the merger, Jan was Head of Preclinical Affairs, Astra AB, with responsibilities for Discovery build up of enabling technologies, project co-ordination and evaluation. Jan has a medical education from University of Gothenburg and was a professor at the Department of Pharmacology at the Karolinska Institute in Stockholm before joining Astra AB. He has published more than 500 scientific articles, mainly related to mechanisms of cell signalling in the nervous-, cardiovascular-, and respiratory systems. Jan has won a variety of research awards and he is a highly cited author on www.isihighlycited.com in the areas of Biology & Biochemistry, Pharmacology and Neuroscience. Jan has been a member of the Swedish Medical Research Council and also of the Advisory Board for Drug Approvals at the Swedish Medical Product Agency. In January 2003, he was appointed Honorary Director of Pharmacy at Uppsala University. | 